These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3301902)

  • 21. Antilipolytic effects of N6-phenylisopropyladenosine and prostaglandin E2 in fat-cells of obese volunteers before and during energy restriction.
    Kather H; Wieland E; Fischer B; Schlierf G
    Biochem J; 1985 Nov; 231(3):531-5. PubMed ID: 3865651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of lipolysis in adipose tissue.
    Meisner H; Carter JR
    Horiz Biochem Biophys; 1977; 4():91-129. PubMed ID: 202557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of prostaglandin E2, phenylisopropyladenosine, clonidine and propranolol on lipolysis stimulated by methylisobutylxanthine and isoprenaline in hamster fat cells.
    Tan S; Curtis-Prior PB
    Prostaglandins Leukot Med; 1985 Feb; 17(2):183-90. PubMed ID: 2580319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in lipolysis between human subcutaneous and omental adipose tissues.
    Arner P
    Ann Med; 1995 Aug; 27(4):435-8. PubMed ID: 8519504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of N6-phenylisopropyladenosine on the regulation of fat cell hexose transport, glucose oxidation and fatty acid release by insulin and catecholamines.
    Souness JE; Thompson WJ; Strada SJ; Stouffer JE
    FEBS Lett; 1983 Mar; 153(1):103-7. PubMed ID: 6337875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated adenosine R-site effect in adipocytes in obesity.
    Ohisalo JJ; Ranta S; Huhtaniemi IT
    Metabolism; 1986 Feb; 35(2):143-6. PubMed ID: 3003494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional differences in the lipolytic response of the subcutaneous fat depots to prolonged exercise and severe energy deficiency.
    Rognum TO; Rodahl K; Opstad PK
    Eur J Appl Physiol Occup Physiol; 1982; 49(3):401-8. PubMed ID: 6890451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permissive effects on adipose tissue lipolysis of a plasmatic factor which inhibits prostaglandin biosynthesis.
    Curtis-Prior PB; Oblin AR; Tan S
    Prostaglandins Med; 1979 Dec; 3(6):361-6. PubMed ID: 550159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Energy cost of fat-fuel mobilization in geriatric trauma.
    Jeevanandam M; Young DH; Schiller WR
    Metabolism; 1990 Feb; 39(2):144-9. PubMed ID: 2299986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of "local" hormones in regulation of lipolysis.
    Kather H
    Prostaglandins; 1987 Jun; 33(6):831-6. PubMed ID: 3313524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid levels and "affluent" diets.
    Mann GV
    N Engl J Med; 1992 Jul; 327(1):52; discussion 53-4. PubMed ID: 1598109
    [No Abstract]   [Full Text] [Related]  

  • 32. The doctor prescribed a fat-free diet for stem cell mobilization.
    Kollet O; Khatib-Massalha E; Lapidot T
    Haematologica; 2021 Jun; 106(6):1512-1513. PubMed ID: 33538158
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired Metabolic Flexibility to High-Fat Overfeeding Predicts Future Weight Gain in Healthy Adults.
    Begaye B; Vinales KL; Hollstein T; Ando T; Walter M; Bogardus C; Krakoff J; Piaggi P
    Diabetes; 2020 Feb; 69(2):181-192. PubMed ID: 31712321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vitro lipolysis is associated with whole-body lipid oxidation and weight gain in humans.
    Frankl J; Piaggi P; Foley JE; Krakoff J; Votruba SB
    Obesity (Silver Spring); 2017 Jan; 25(1):207-214. PubMed ID: 27868388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TGH and its role in porcine primary adipocyte lipolysis.
    Zhang LH; Zhang LJ; Wang Q; Wang B; Yang GS
    Mol Cell Biochem; 2008 Aug; 315(1-2):159-67. PubMed ID: 18543084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
    Reynisdottir S; Ellerfeldt K; Wahrenberg H; Lithell H; Arner P
    J Clin Invest; 1994 Jun; 93(6):2590-9. PubMed ID: 8200997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors.
    Reynisdottir S; Wahrenberg H; Carlström K; Rössner S; Arner P
    Diabetologia; 1994 Apr; 37(4):428-35. PubMed ID: 8063046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
    Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
    J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The stimulus-sensitive H2O2-generating system present in human fat-cell plasma membranes is multireceptor-linked and under antagonistic control by hormones and cytokines.
    Krieger-Brauer HI; Kather H
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):543-8. PubMed ID: 7733895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.